Abstract
Micro-Abstract Myelomatous involvement of the central nervous system (CNS) is an uncommon complication that portends a poor prognosis in patients with multiple myeloma (MM). Limited data exist regarding the optimal management of CNS MM. In the present case-control study, we examined the clinical presentation, diagnosis, treatment, and outcomes of CNS MM patients compared with a control group of MM patients without CNS involvement, matched by date of diagnosis and gender.
Original language | English (US) |
---|---|
Pages (from-to) | 644-654 |
Number of pages | 11 |
Journal | Clinical Lymphoma, Myeloma and Leukemia |
Volume | 16 |
Issue number | 11 |
DOIs | |
State | Published - Nov 1 2016 |
Keywords
- Extramedullary
- High-risk
- Leptomeningeal
- Multiple myeloma
- Outcome
ASJC Scopus subject areas
- Hematology
- Oncology
- Cancer Research